Level III axillary lymph nodes involvement in node positive breast cancer received neoadjuvant chemotherapy.

[1]  S. Ciatto,et al.  Preoperative Ultrasound-Guided Needle Biopsy of Axillary Nodes in Invasive Breast Cancer: Meta-Analysis of Its Accuracy and Utility in Staging the Axilla , 2011, Annals of surgery.

[2]  T. Julian,et al.  Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. , 2010, The Lancet. Oncology.

[3]  M. Dillon,et al.  The Value of Level III Clearance in Patients With Axillary and Sentinel Node Positive Breast Cancer , 2009, Annals of surgery.

[4]  R. Storm,et al.  Prevention of futile sentinel node procedures in breast cancer: ultrasonography of the axilla and fine-needle aspiration cytology are obligatory. , 2008, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[5]  N. Ahuja,et al.  The Role of Ultrasound-Guided Fine-Needle Aspiration of Axillary Nodes in the Staging of Breast Cancer , 2008, Annals of Surgical Oncology.

[6]  E. Yıldırım,et al.  Lymph Node Ratio is More Valuable than Level III Involvement for Prediction of Outcome in Node-Positive Breast Carcinoma Patients , 2007, World Journal of Surgery.

[7]  Y. Nio,et al.  Ten-year follow-up results of a randomised controlled study comparing level-I vs level-III axillary lymph node dissection for primary breast cancer , 2006, British Journal of Cancer.

[8]  M. Hočevar,et al.  Patients with preoperatively ultrasonically uninvolved axillary lymph nodes: a distinct subgroup of early breast cancer patients , 2006, Breast Cancer Research and Treatment.

[9]  Xue-juan Wang,et al.  [Preliminary study of new imaging agent, 99mTc-Rituximab, for sentinel lymph node biopsy of primary breast cancer]. , 2006, Zhonghua wai ke za zhi [Chinese journal of surgery].

[10]  Xue-juan Wang,et al.  [Preliminary study on a new sentinel lymphoscintigraphy agent 99mTc-Rituximab for breast patient]. , 2006, Zhonghua zhong liu za zhi [Chinese journal of oncology].

[11]  G. Hortobagyi,et al.  Outcome after pathologic complete eradication of cytologically proven breast cancer axillary node metastases following primary chemotherapy. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  Jin-feng Li,et al.  [Exploration of the extent of axillary dissection for patients with node positive primary breast cancer]. , 2005, Zhonghua wai ke za zhi [Chinese journal of surgery].

[13]  S. Takashima,et al.  Randomized clinical trial comparing level II and level III axillary node dissection in addition to mastectomy for breast cancer , 2004, British Journal of Surgery.

[14]  E. Petru,et al.  T1 Breast Cancer: Identification of Patients at Low Risk of Axillary Lymph Node Metastases , 2002, Breast Cancer Research and Treatment.

[15]  Boon Chua,et al.  Is there a role for axillary dissection for patients with operable breast cancer in this era of conservatism?* , 2002, ANZ journal of surgery.

[16]  A. Vincent-Salomon,et al.  Incidence and prognostic significance of complete axillary downstaging after primary chemotherapy in breast cancer patients with T1 to T3 tumors and cytologically proven axillary metastatic lymph nodes. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  Richard J. K. Taylor,et al.  Frequency and predictors of axillary lymph node metastases in invasive breast cancer , 2001, ANZ journal of surgery.

[18]  P B Cerrito,et al.  Sentinel lymph node biopsy for breast cancer: a suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  S. Gapstur,et al.  Factors associated with axillary lymph node metastasis from breast carcinoma , 1999, Cancer.

[20]  R. Severson,et al.  Axillary lymph node metastases associated with small invasive breast carcinomas , 1999, Cancer.

[21]  R. Foster,et al.  The sentinel node in breast cancer--a multicenter validation study. , 1998, The New England journal of medicine.

[22]  J. Ragaz,et al.  Prediction of axillary lymph node involvement of women with invasive breast carcinoma , 1998, Cancer.

[23]  P. Bruzzi,et al.  Prognostic role of lymph-node level involvement in patients undergoing axillary dissection for breast cancer. , 1998, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[24]  A E Giuliano,et al.  Sentinel lymphadenectomy in breast cancer. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  A. Hanlon,et al.  Identification of women with T1‐T2 breast cancer at low risk of positive axillary nodes , 1997, Journal of surgical oncology.

[26]  A. Recht,et al.  Axillary lymph nodes and breast cancer. A review , 1995, Cancer.

[27]  P M Ravdin,et al.  Prediction of axillary lymph node status in breast cancer patients by use of prognostic indicators. , 1994, Journal of the National Cancer Institute.

[28]  S. Bonassi,et al.  Predictive value of some clinical and pathological parameters on upper level axillary lymph node involvement in breast cancer. , 1991, Anticancer research.

[29]  A. Luini,et al.  Extent of metastatic axillary involvement in 1446 cases of breast cancer. , 1990, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[30]  Yang Wei-we.  A Review on , 2008 .

[31]  J. Peterse,et al.  Ultrasonography and Fine-Needle Aspiration Cytology Can Spare Breast Cancer Patients Unnecessary Sentinel Lymph Node Biopsy , 2006, Annals of Surgical Oncology.

[32]  M. Silverstein,et al.  Predictors of axillary lymph node metastases in patients with T1 breast carcinoma , 1997, Cancer.